Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

Healthcare Technology Drug Manufacturers - Specialty & Generic Software - Application Cannabis
GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

GB Group Ord Shs > CanniMed Therapeutics Forms Special Committee for Potential
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GreyMatter22on Nov 22, 2017 8:43pm
93 Views
Post# 27016001

RE:RE:RE:CanniMed Therapeutics Forms Special Committee for Potential

RE:RE:RE:CanniMed Therapeutics Forms Special Committee for Potential
VENMan wrote: The 20 VWAP based on closing prices for ACB not including todays trading day is $5.06 as I calculate it. If ACB wants to give CMED $24 then hand over 4.75 ACB shares for every CMED and keep it that way no matter what happens to ACB shares on a trading day up or down. It's always 4.75 ACB shares for 1 CMED share. Doing somthing like this the market will know exactly how much dilution will effect ACB shares and if buying CMED shares you know exactly how many ACB shares you get when you buy and the two companies can trade in unison when and IF the deal goes through! Ok, I'm done! ALL IMO, DYODD  



It is true that ACB is trading at all time highs, but CMED is also trading at all time high as well, in fact the price from $15 jumped to the $19-21 range as soon as ACB interest came about. I would prefer ACB over HIP of all companies anyway.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities